Total debt plummeted from $5.1B to $43M in 2026Q2, driving D/E to 0.01, while retained earnings deficit widened to -$1.0B and goodwill of $4.7B (34% of assets) remains an impairment risk.
Bausch + Lomb Corporation (BLCO) balance sheet — 7-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 |
|---|
| Total Current Assets | 2.92B | 2.98B | 2.79B | 2.74B | 2.14B | 1.64B | 1.65B | 1.7B |
| Cash & Short-Term Investments | 367M | 383M | 305M | 334M | 380M | 174M | 238M | 192M |
| Cash Only | 367M | 383M | 305M | 334M | 380M | 174M | 238M | 192M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.16B | 1.22B | 1.03B | 875M | 726M | 721M | 645M | 713M |
| Days Sales Outstanding | 78.59 | 87.37 | 78.17 | 77.03 | 70.33 | 69.9 | 69 | 68.88 |
| Inventory | 999M | 976M | 1.04B | 1.03B | 628M | 572M | 616M | 592M |
| Days Inventory Outstanding | 158.71 | 154.35 | 202 | 228.51 | 150.9 | 142.32 | 174.97 | 162.83 |
| Other Current Assets | 396M | 397M | 421M | 505M | 403M | 3M | 155M | 198M |
| Total Non-Current Assets | 10.94B | 11.04B | 10.68B | 10.7B | 9.01B | 9.19B | 9.61B | 9.77B |
| Property, Plant & Equipment | 1.8B | 1.76B | 1.49B | 1.5B | 1.42B | 1.23B | 1.26B | 1.09B |
| Fixed Asset Turnover | 3.01x | 2.90x | 3.23x | 2.76x | 2.66x | 3.07x | 2.70x | 3.47x |
| Goodwill | 4.72B | 4.76B | 4.52B | 4.58B | 4.51B | 4.59B | 4.68B | 4.55B |
| Intangible Assets | 3.17B | 3.28B | 3.49B | 3.59B | 2.06B | 2.26B | 2.56B | 2.85B |
| Long-Term Investments | 7M | 7M | 19M | 19M | 12M | 0 | 0 | 0 |
| Other Non-Current Assets | 294M | 303M | 275M | 92M | 84M | 180M | 65M | 82M |
| Total Assets | 13.86B | 14.02B | 13.47B | 13.44B | 11.14B | 10.82B | 11.27B | 11.47B |
| Asset Turnover | 0.38x | 0.36x | 0.36x | 0.31x | 0.34x | 0.35x | 0.30x | 0.33x |
| Asset Growth % | 9.27% | 4.11% | 0.2% | 20.62% | 2.97% | -3.93% | -1.76% | - |
| Total Current Liabilities | 1.89B | 1.92B | 1.74B | 1.58B | 1.3B | 1.1B | 909M | 1.03B |
| Accounts Payable | 426M | 388M | 389M | 522M | 317M | 239M | 178M | 262M |
| Days Payables Outstanding | 64.82 | 61.36 | 75.85 | 116.04 | 76.17 | 59.46 | 50.56 | 72.06 |
| Short-Term Debt | 43M | 77M | 40M | 57M | 51M | 28M | 18M | 16M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.42B | 1.46B | 459M | 709M | 732M | 356M | 544M | 573M |
| Current Ratio | 1.55x | 1.55x | 1.60x | 1.74x | 1.65x | 1.49x | 1.82x | 1.64x |
| Quick Ratio | 1.02x | 1.04x | 1.01x | 1.09x | 1.16x | 0.97x | 1.14x | 1.07x |
| Cash Conversion Cycle | 172.49 | 180.36 | 204.32 | 189.51 | 145.06 | 152.75 | 193.41 | 159.65 |
| Total Non-Current Liabilities | 5.53B | 5.58B | 5.19B | 4.94B | 2.75B | 322M | 369M | 401M |
| Long-Term Debt | 0 | 5.17B | 4.74B | 4.53B | 2.41B | 0 | 0 | 0 |
| Capital Lease Obligations | 125M | 125M | 120M | 87M | 92M | 92M | 83M | 77M |
| Deferred Tax Liabilities | 70M | 19M | 13M | 14M | 7M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 5.51B | 271M | 310M | 310M | 237M | 230M | 286M | 324M |
| Total Liabilities | 7.42B | 7.5B | 6.92B | 6.52B | 4.04B | 1.42B | 1.28B | 1.44B |
| Total Debt | 43M | 5.37B | 4.94B | 4.68B | 2.55B | 140M | 101M | 93M |
| Net Debt | -324M | 4.99B | 4.63B | 4.34B | 2.17B | -34M | -137M | -99M |
| Debt / Equity | 0.01x | 0.82x | 0.75x | 0.68x | 0.36x | 0.01x | 0.01x | 0.01x |
| Debt / EBITDA | 0.05x | 8.82x | 8.25x | 9.13x | 4.36x | 0.19x | 0.14x | 0.11x |
| Net Debt / EBITDA | -0.41x | 8.19x | 7.74x | 8.48x | 3.71x | -0.05x | -0.20x | -0.11x |
| Interest Coverage | 0.84x | 0.26x | 0.41x | 0.41x | 1.50x | - | - | - |
| Total Equity | 6.44B | 6.52B | 6.54B | 6.92B | 7.1B | 9.4B | 9.99B | 10.03B |
| Equity Growth % | -3.49% | -0.38% | -5.43% | -2.55% | -24.47% | -5.87% | -0.44% | - |
| Book Value per Share | 18.05 | 18.43 | 18.60 | 19.74 | 20.29 | 26.86 | 28.54 | 28.66 |
| Total Shareholders' Equity | 6.38B | 6.45B | 6.47B | 6.85B | 7.03B | 9.33B | 9.92B | 9.96B |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 10.36B | 10.81B | 11.01B |
| Retained Earnings | -1.02B | -931M | -571M | -254M | 6M | 0 | 0 | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -1.22B | -1.18B | -1.39B | -1.25B | -1.26B | -1.03B | -889M | -1.05B |
| Minority Interest | 68M | 71M | 71M | 70M | 68M | 73M | 70M | 73M |
Quick answers to the most common questions about buying BLCO stock.
As of 2025, Bausch + Lomb Corporation (BLCO) had total assets of $14.02B including $2.98B in current assets.
Bausch + Lomb Corporation (BLCO) carries total debt of $5.37B, offset by $383.0M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Bausch + Lomb Corporation (BLCO) has total shareholders' equity (book value) of $6.45B ($18.43 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Bausch + Lomb Corporation (BLCO) reported a current ratio of 1.55x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Goodwill impairment risk
Metrics are mathematically derived from official filings.
Balance Sheet Stability Amidst Growth
Total assets grew from $13.3B in 2024Q1 to $13.9B in 2026Q2, while equity remained near $6.4B, indicating a stable balance sheet despite revenue acceleration, per reported figures.
The balance sheet has remained remarkably stable over the past ten quarters, with total assets hovering around $13.5B and equity consistently near $6.4B. This stability, despite revenue growth of 8.7% year-over-year in 2026Q2, suggests that the company is funding its expansion without significant balance sheet expansion, possibly through operational cash flow. The slight increase in assets is driven by growth in PPE and intangibles, but the overall leverage has not increased, indicating a disciplined approach to capital deployment.
Leverage Drops Sharply in 2026Q2
Total debt plummeted from $5.1B in 2026Q1 to $43M in 2026Q2, driving D/E from 0.79 to 0.01, as per the latest balance sheet, suggesting a major debt repayment or restructuring.
The dramatic reduction in total debt in 2026Q2 is a significant event, as D/E fell from 0.79 to 0.01. This appears to be a strategic deleveraging, possibly through a debt repayment or refinancing, which substantially reduces interest expense and refinancing risk. However, the suddenness warrants investigation into the source of funds, as cash only increased by $99M, implying the repayment may have been funded by other means, such as asset sales or equity issuance, which could have implications for equity quality.
Asset Mix Reflects Acquisition-Driven Growth
Goodwill and intangibles constitute approximately 34% of total assets at $4.7B, with PPE growing steadily to $1.8B, as reported in financial statements, indicating a mix of acquisition-led and organic investment.
The asset base is heavily weighted towards goodwill and intangibles, which have remained stable around $4.7B, suggesting that past acquisitions have not been impaired but also that the company's growth is partly dependent on acquired assets. PPE has grown from $1.4B to $1.8B over the period, indicating ongoing investment in fixed assets, which aligns with the moderate capex intensity noted in cash flow analysis. The stability of goodwill is a positive sign, but investors should monitor for potential impairment if growth slows.
Retained Earnings Deficit Widens
Retained earnings deteriorated from -$421M in 2024Q1 to -$1.0B in 2026Q2, reflecting cumulative net losses, while equity remained flat at $6.4B, per balance sheet data, suggesting offsetting equity injections.
The retained earnings deficit has more than doubled over the period, from -$421M to -$1.0B, consistent with the cumulative net losses reported in the income statement. Despite this, total equity has remained stable at around $6.4B, implying that other equity components, such as additional paid-in capital, have been increased, possibly through equity issuances or conversions. This suggests that the company is relying on external equity to offset losses, which could dilute existing shareholders if not managed carefully.
Liquidity Position Remains Adequate
Current ratio improved to 1.55 in 2026Q2 from 1.70 in 2024Q1, with cash at $367M, as per the balance sheet, indicating a stable but slightly reduced liquidity buffer.
The current ratio has declined from 1.70 to 1.55 over the period, but remains above 1.5, indicating that current assets comfortably cover current liabilities. Cash has fluctuated between $202M and $383M, with 2026Q2 at $367M, providing a modest buffer against short-term shocks. Given the company's positive operating cash flow in most quarters, liquidity appears adequate, though the low cash balance relative to total assets suggests reliance on operating cash flow and credit facilities for working capital needs.
Goodwill Impairment Risk Looms
Goodwill of $4.7B represents 34% of total assets, and with cumulative net losses exceeding $1B, as per balance sheet data, there is elevated risk of future impairment charges.
The substantial goodwill on the balance sheet, combined with persistent net losses, raises the risk of future impairment charges. While goodwill has remained stable, the company's inability to generate consistent profits may indicate that the carrying value of acquired assets is not fully supported by cash flows. If revenue growth decelerates or margins fail to improve, an impairment could significantly reduce equity and total assets, potentially impacting leverage ratios and investor confidence. This is a non-obvious risk that headline numbers may not fully capture.